Aurora Investment Counsel’s AstraZeneca AZN Stock Holding History

Aurora Investment Counsel’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.39M	Sell	12,616 -218	-2%	-$41K	1.23%	21
2026 Q1	$2.53M	Buy	+12,834	New	+$2.47M	1.4%	16
2025 Q4	–	Sell	-18,213	Closed	-$2.79M	–	107
2025 Q3	$2.79M	Sell	18,213 -130	-0.7%	-$19.7K	1.46%	10
2025 Q2	$2.56M	Buy	18,343 +225	+1%	+$31.5K	1.35%	15
2025 Q1	$2.66M	Sell	18,118 -200	-1%	-$28.9K	1.48%	12
2024 Q4	$2.4M	Buy	18,318 +1,425	+8%	+$200K	1.31%	20
2024 Q3	$2.63M	Sell	16,893 -2,587	-13%	-$418K	1.42%	11
2024 Q2	$3.04M	Sell	19,480 -1,378	-7%	-$207K	1.78%	2
2024 Q1	$2.83M	Buy	20,858 +2,687	+15%	+$356K	1.62%	2
2023 Q4	$2.54M	Buy	18,171 +352	+2%	+$45.8K	1.65%	1
2023 Q3	$2.41M	Buy	+17,819	New	+$2.43M	1.6%	1

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aurora Investment Counsel's AZN Position: Q2 2026 in Review

Aurora Investment Counsel reduced its AstraZeneca (AZN) stake by 1.7% in Q2 2026, selling an estimated $41K and leaving 12,616 shares worth $2.39M. The position accounts for 1.23% of the portfolio, ranked #21.

Aurora Investment Counsel first reported a position in AZN in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.04M in Q2 2024. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Aurora Investment Counsel held 12,616 shares of AstraZeneca worth $2.39M as of Q2 2026.
Aurora Investment Counsel sold 218 AstraZeneca shares in Q2 2026, an estimated $41K.
AstraZeneca made up 1.23% of Aurora Investment Counsel's portfolio in Q2 2026, its #21 holding.
Aurora Investment Counsel first reported a position in AstraZeneca in Q3 2023 and has held it in 11 quarters since.
Aurora Investment Counsel's AstraZeneca position peaked at $3.04M in Q2 2024.
1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Aurora Investment Counsel's 13F filing for Q2 2026, filed 10 Aug 2026.